Amal Therapeutics competitorsClear all
Amal Therapeutics's top competitors include Neovii, Foghorn Therapeutics and Reflexion Medical.
 Amal Therapeutics Amal Therapeutics is a biotech company, which engages in the research and development of therapeutic vaccines in oncology. |  Neovii Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
|  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. |  Reflexion Medical RefleXion Medical is developing the biology-guided radiotherapy system for cancer treatment. | |
Founding Date | Founding Date N/A | Founding Date 2003 | Founding Date 2016 | Founding Date 2009 |
Type | Type Subsidiary | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations Genève, CH HQ | Locations Rapperswil-Jona, CH HQ Gräfelfing, DE Lexington, US | Locations Cambridge, US HQ Cambridge, US | Locations Hayward, US HQ |
Employees | Employees 225% increase | Employees 89 | Employees 85 | Employees 2501% increase |
Twitter followers | Twitter followers N/A | Twitter followers N/A | Twitter followers 880 | Twitter followers 3 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 6 | Number of tweets (last 30 days) 19 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 3 | Average likes per tweet (last 30 days) 5.3 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% |
Alexa Website Rank | Alexa Website Rank 122274 | Alexa Website Rank N/A | Alexa Website Rank 340238 | Alexa Website Rank 445159 |
Employee Rating | Employee Rating N/A | Employee Rating N/A | Employee Rating 4 | Employee Rating 4.4 |
Funding | ||||
Total funding raised | Total funding raised $ 45.5m | Total funding raised N/A | Total funding raised $ 50m | Total funding raised $ 263.6m |
For sources of this data, please see the company profile
View company profiles
Neovii
HQ
Rapperswil-Jona, CH
Employees
89
Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
View companyFoghorn Therapeutics
HQ
Cambridge, US
Employees
85
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View companyReflexion Medical
HQ
Hayward, US
Employees
250↑ 1% increase
RefleXion Medical is developing the biology-guided radiotherapy system for cancer treatment.
View company